Gunda Georg, Ph.D., is an esteemed researcher and professor in the College of Pharmacy at the University of Minnesota. As head of the Department of Medical Chemistry, Georg has made a tremendous impact in the field of synthetic medicinal chemistry.

Georg is also the director of the Institute for Therapeutics Discovery and Development and holds both the Robert Vince Endowed Chair in Medicinal Chemistry and McKnight Presidential Chair. This July she will receive the prestigious Volwiler Research Achievement Award for her research accomplishments.

A team funded by the Minnesota Partnership for Biotechnology and Medical Genomics has uncovered clues to possible drugs for two rare cancers through research involving baker’s yeast and a library of chemical compounds.

February 28 is observed internationally as Rare Disease Day. Nearly 30 million people in the United States suffer from conditions classified as “rare diseases”.

While some bear names you’ve likely never heard of, other examples may surprise you …

At the University’s new AeroCore Center, the medicine is small but its potential is huge. At the AeroCore Center, researchers from across the U of M have partnered to find a better way to eradicate dangerous lung cancer cells with a simple process: inhalation of nanoparticles.

Okay, maybe their solution isn’t so simple …

It might sound like something out of a classic spy thriller, but University of Minnesota researchers are working on a new antidote for one of history’s most lethal chemical agents: cyanide …

The effectiveness of the flu vaccine is a hot topic as this season of influenza has brought with it hospitalizations and untimely deaths.

WCCO’s Good Question asked: why isn’t the flu shot more effective?

“Influenza isn’t like mumps or measles; it constantly changes,” explained Michael Osterholm, Ph.D., professor in the School of Public Health. “Vaccine makers try to account for that by predicting which strains will be out there, and matching the vaccine.”

He adds, “We’ve seen years when the match was supposedly very good, and vaccine protection was really bad. We’ve seen years where the match wasn’t very good, and yet vaccine protection was above average.”

A recent study led by Osterholm, director of the Center for Infectious Disease Research and Policy (CIDRAP), found current influenza vaccines offer less protection against seasonal influenza than previously reported.